Wird geladen...
Lessons from the infuse trials: do we need a classification of bias in scientific publications and editorials?
The original 13 Food and Drug Administration industry-sponsored recombinant human bone morphogenetic protein-2 (rhBMP-2) trials investigating its use in spinal fusion all reported no associated adverse events. However, subsequent series of studies began reporting complication rates that were much hi...
Gespeichert in:
| Veröffentlicht in: | Curr Rev Musculoskelet Med |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer US
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4596163/ https://ncbi.nlm.nih.gov/pubmed/24878967 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12178-014-9223-1 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|